Literature DB >> 16385093

Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials?

Martha Vargas1, Juan P Horcajada, Victor Obach, Marina Revilla, Alvaro Cervera, Ferrán Torres, Anna M Planas, Josep Mensa, Angel Chamorro.   

Abstract

BACKGROUND AND
PURPOSE: It is unsettled whether stroke-associated infection (SAI) is an independent prognostic factor, and a recent clinical trial failed to show that antibiotic prophylaxis prevented SAI. Contrarily, this trial suggested that antibiotic prophylaxis impaired clinical recovery. We sought to evaluate the predisposing factors and clinical consequences of SAI to gather additional insight on the need of exploring other antibiotics in acute stroke.
METHODS: Between March 2001 and April 2002, 229 consecutive patients were admitted into the neurological wards within 24 hours of stroke onset. Demographics, risk factors, National Institutes of Health Stroke Scale (NIHSS) score, vital data, imaging, and laboratory findings were prospectively evaluated. SAI was treated as early as possible. Multivariate regression analyses assessed predisposing factors of SAI and the independent association between SAI and poor stroke outcome at day 7 (Rankin >2).
RESULTS: Sixty (26%) patients developed SAI, most frequently chest infections, and within 3 days of stroke onset. Tube feeding (odds ratio [OR], 3.2; 95% CI, 1.3, 7.8) was the strongest predisposing factor of SAI. Poor outcome at hospital discharge was associated to baseline NIHSS score (OR, 10.0; 95% CI, 1.5, 100) and tube feeding (OR, 16.6; 95% CI, 2.9, 100.0), adjusted for confounders including antibiotic use. SAI was not independently associated to poor outcome (OR, 0.9; 95% CI, 0.9, 1.0).
CONCLUSIONS: SAI is a marker of the severity of stroke without an independent outcome effect when it is promptly treated. These results support current stroke guidelines that advise prompt treatment of infection and warn against antibiotic prophylaxis. Yet, these recommendations should not prevent the performance of acute stroke trials assessing the value of antibiotics with acknowledged neuroprotective properties.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16385093     DOI: 10.1161/01.STR.0000199138.73365.b3

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  39 in total

Review 1.  Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS?

Authors:  Catherine E Downes; Peter J Crack
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Ischaemic brain damage after stroke: new insights into efficient therapeutic strategies. International Symposium on Neurodegeneration and Neuroprotection.

Authors:  Carsten Culmsee; Josef Krieglstein
Journal:  EMBO Rep       Date:  2007-01-12       Impact factor: 8.807

3.  Infection after intracerebral hemorrhage: risk factors and association with outcomes in the ethnic/racial variations of intracerebral hemorrhage study.

Authors:  Aaron S Lord; Carl D Langefeld; Padmini Sekar; Charles J Moomaw; Neeraj Badjatia; Anastasia Vashkevich; Jonathan Rosand; Jennifer Osborne; Daniel Woo; Mitchell S V Elkind
Journal:  Stroke       Date:  2014-10-14       Impact factor: 7.914

4.  Infections Increase the Risk of 30-Day Readmissions Among Stroke Survivors.

Authors:  Amelia K Boehme; Erin R Kulick; Michelle Canning; Trevor Alvord; Bijan Khaksari; Setareh Omran; Joshua Z Willey; Mitchell S V Elkind
Journal:  Stroke       Date:  2018-12       Impact factor: 7.914

5.  Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke.

Authors:  A Chamorro; S Amaro; M Vargas; V Obach; A Cervera; F Torres; A M Planas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11       Impact factor: 10.154

Review 6.  Prophylactic Antibiotic Therapy for Preventing Poststroke Infection.

Authors:  Stefan Schwarz
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

7.  Arginase I release from activated neutrophils induces peripheral immunosuppression in a murine model of stroke.

Authors:  Trisha R Sippel; Takeru Shimizu; Frank Strnad; Richard J Traystman; Paco S Herson; Allen Waziri
Journal:  J Cereb Blood Flow Metab       Date:  2015-05-13       Impact factor: 6.200

8.  [Patient characteristics and factors associated with unfavourable in-hospital rehabilitation therapy outcome in very old geriatric patients with first-ever ischemic stroke--a retrospective case-control study].

Authors:  K Hegener; T Krause; W von Renteln-Kruse
Journal:  Z Gerontol Geriatr       Date:  2007-12       Impact factor: 1.281

Review 9.  The Local and Peripheral Immune Responses to Stroke: Implications for Therapeutic Development.

Authors:  Kristy A Zera; Marion S Buckwalter
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

10.  Preventive Ceftriaxone in Patients with Stroke Treated with Intravenous Thrombolysis: Post Hoc Analysis of the Preventive Antibiotics in Stroke Study.

Authors:  Jan-Dirk Vermeij; Willeke F Westendorp; Yvo B Roos; Matthijs C Brouwer; Diederik van de Beek; Paul J Nederkoorn
Journal:  Cerebrovasc Dis       Date:  2016-06-24       Impact factor: 2.762

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.